Global Frontier Investments’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-505,000
Closed -$7.14M 18
2022
Q4
$3.69M Hold
505,000
1.62% 16
2022
Q3
$3.5M Buy
505,000
+70,000
+16% +$522K 1.77% 16
2022
Q2
$3.04M Hold
435,000
1.42% 17
2022
Q1
$3.6M Hold
435,000
1.39% 17
2021
Q4
$4.7M Buy
435,000
+25,000
+6% +$270K 1.77% 16
2021
Q3
$4.94M Buy
410,000
+95,000
+30% +$1.07M 3.6% 10
2021
Q2
$3.82M Buy
315,000
+190,000
+152% +$2.36M 2.89% 12
2021
Q1
$1.74M Hold
125,000
1.5% 17
2020
Q4
$1.77M Hold
125,000
1.72% 18
2020
Q3
$1.54M Buy
+125,000
New +$1.45M 2.28% 17

Other funds holding AMYT

Global Frontier Investments's AMYT Position: Q1 2023 in Review

Global Frontier Investments sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 505,000 shares — an estimated $7.14M sold.

Global Frontier Investments first reported a position in AMYT in Q3 2020 and held it in 10 quarters. The position peaked at $4.94M in Q3 2021. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Global Frontier Investments reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Global Frontier Investments sold 505,000 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $7.14M.
  • Global Frontier Investments first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 10 quarters.
  • Global Frontier Investments's Amryt Pharma plc American Depositary Shares position peaked at $4.94M in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Global Frontier Investments's 13F filing for Q1 2023, filed 12 May 2023.